Continued refinement in the treatment of germ cell tumour patients
- 30 June 1991
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (6) , 677-678
- https://doi.org/10.1016/0277-5379(91)90162-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.Journal of Clinical Oncology, 1991
- Two-drug therapy in patients with metastatic germ cell tumorsCancer, 1991
- Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.Journal of Clinical Oncology, 1989
- Prognostic factors for relapse after complete response in patients with metastatic germ cell tumorsCancer, 1989
- A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.Journal of Clinical Oncology, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratomaBritish Journal of Cancer, 1984
- Vascular and other complications of chemotherapy for testicular cancerWorld Journal of Urology, 1984
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular CancerAnnals of Internal Medicine, 1981